A scientist who turned corporate to transform research into revenue, I transitioned from academia into government R&D and later into industry—connecting these three worlds to strengthen the full cycle of innovation and research commercialization. With 15+ years of cross-disciplinary experience in biotechnology, I have led research teams and initiatives that bridge science and industry.
My expertise spans R&D strategy, omics, drug discovery, bioengineering, and bioproduction—turning scientific breakthroughs into high-value, commercially viable products. I have a strong track record of building partnerships across industry, government, and academia to deliver scalable innovations that generate both revenue and impact. Today, I head commercial R&D at the intersection of human and environmental health, advancing solutions where innovation meets commercial value.
Participa en
Oct 12 2025 (11:00 - 12:30)